Clinical Trial Update: Delayed SLND for Patients With Breast Cancer Undergoing Primary Systemic Treatment

View source ↗

Summary

The study evaluating delayed sentinel lymph node dissection in breast cancer patients receiving primary systemic therapy is currently ACTIVE_NOT_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Uppsala University | Conditions: Breast Cancer, Chemotherapy Effect | Status: ACTIVE_NOT_RECRUITING